Complete Up To Date Information about Bapten For Injection.
NADA Number: 141-107 | |
| Proprietary Name |
Bapten® For Injection |
|---|---|
| Sponsor |
Alaco, Inc. |
| Sponsor Address |
1500 North Wilmot Rd Suite 290-C Tuscon, AZ 85712 USA |
| Ingredients |
Beta-aminopropionitrile |
| Species |
Horse, excluding breeding stock and not for food |
| Routes of Administration |
Intralesional |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
| Patent Number |
4485088 |
| Exclusivity |
No active ingredient of the drug has been previously approved. |
|
Dosage Amount, Indications & Limitations |
522.84 Beta-aminopropionitrile fumarate. Specifications: Each vial contains 7.0 milligrams of beta-aminopropionitrile fumarate sterile lyophilized powder which is reconstituted for injection with 10 milliliters of sterile physiologic saline, USP. Conditions of use: Horses Amount: 7 milligrams (10 milliliters) intralesionally every other day for 5 treatments beginning about 30 days after initial injury. Single dose container for intralesional injection. Indications: For treatment of tendinitis of the superficial digital flexor tendon (SDFT) in the adult horse where there is sonographic evidence of fiber tearing. Limitations: Do not use in horses with dermal irritation or open skin lesions in the injection area. Do not administer intra-articularly, into the tendon sheath, or in the presence of concurrent limb fractures. Do not use in breeding animals since the effects on fertility, pregnancy, or fetal health have not been determined. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |